Format

Send to

Choose Destination
Biol Psychiatry. 2017 Oct 1;82(7):472-487. doi: 10.1016/j.biopsych.2016.12.031. Epub 2017 Feb 24.

Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice.

Author information

1
APC Microbiome Institute, University College Cork, Cork.
2
APC Microbiome Institute, University College Cork, Cork; Teagasc Food Research Centre, Biosciences Department, Moorepark, Fermoy, Ireland.
3
APC Microbiome Institute, University College Cork, Cork; Department of Psychiatry and Neurobehavioral Science, University College Cork, Cork; Department of Anatomy and Neuroscience, University College Cork, Cork.
4
Teagasc Food Research Centre, Biosciences Department, Moorepark, Fermoy, Ireland.
5
APC Microbiome Institute, University College Cork, Cork; Department of Psychiatry and Neurobehavioral Science, University College Cork, Cork; Department of Anatomy and Neuroscience, University College Cork, Cork. Electronic address: j.cryan@ucc.ie.

Abstract

BACKGROUND:

The realization that the microbiota-gut-brain axis plays a critical role in health and disease, including neuropsychiatric disorders, is rapidly advancing. Nurturing a beneficial gut microbiome with prebiotics, such as fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), is an appealing but underinvestigated microbiota manipulation. Here we tested whether chronic prebiotic treatment modifies behavior across domains relevant to anxiety, depression, cognition, stress response, and social behavior.

METHODS:

C57BL/6J male mice were administered FOS, GOS, or a combination of FOS+GOS for 3 weeks prior to testing. Plasma corticosterone, microbiota composition, and cecal short-chain fatty acids were measured. In addition, FOS+GOS- or water-treated mice were also exposed to chronic psychosocial stress, and behavior, immune, and microbiota parameters were assessed.

RESULTS:

Chronic prebiotic FOS+GOS treatment exhibited both antidepressant and anxiolytic effects. Moreover, the administration of GOS and the FOS+GOS combination reduced stress-induced corticosterone release. Prebiotics modified specific gene expression in the hippocampus and hypothalamus. Regarding short-chain fatty acid concentrations, prebiotic administration increased cecal acetate and propionate and reduced isobutyrate concentrations, changes that correlated significantly with the positive effects seen on behavior. Moreover, FOS+GOS reduced chronic stress-induced elevations in corticosterone and proinflammatory cytokine levels and depression-like and anxiety-like behavior in addition to normalizing the effects of stress on the microbiota.

CONCLUSIONS:

Taken together, these data strongly suggest a beneficial role of prebiotic treatment for stress-related behaviors. These findings strengthen the evidence base supporting therapeutic targeting of the gut microbiota for brain-gut axis disorders, opening new avenues in the field of nutritional neuropsychopharmacology.

KEYWORDS:

Animal behavior; Anxiety; Microbiota-gut-brain axis; Prebiotics; SCFAs; Stress

PMID:
28242013
DOI:
10.1016/j.biopsych.2016.12.031
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center